Freenome Announces $65 Million in Series A Funding, Led by Andreessen Horowitz

09:00 EST 1 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Andreessen Horowitz General Partner, Vijay Pande, to join Freenome Board of Directors Freenome, the health technology company reinventing disease management through systematized early detection and intervention, announced to...

Other Sources for this Article

The OutCast Agency
Christina Valencia, 415-624-4832


More From BioPortfolio on "Freenome Announces $65 Million in Series A Funding, Led by Andreessen Horowitz"

Quick Search


Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...